Full name
EMMES BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
EMMES BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ALEJE JEROZOLIMSKIE 200, 02-486 WARSZAWA
TAX ID7010293763
Rate company:
EMMES BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7010293763
KRS0000383758
Share capital5,000.00 zł
address
UL. ALEJE JEROZOLIMSKIE 200, 02-486 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7010293763
REGON
142902250
KRS
0000383758
Legal form
limited liability company
Register Address
UL. ALEJE JEROZOLIMSKIE 200, 02-486 WARSZAWA
Date of registration in KRS
2011-04-15
Date of commencement of economic activity
2011-04-15
Act signature
WA.XIV NS-REJ.KRS/18944/24/386/ADE
Pkd codes
72.19.Z - Scientific research and development activities
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
68.20.Z - Rental and management of own or leased real estate
70.2 - Business and management consultancy activities
72.1 - Scientific research and development in natural and technical sciences
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.5 - Non-school forms of education
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 1 | 1,2 | 1,3 | 13,9 |
EBITDA | 1 | 1,3 | 1,5 | 21,6 |
Short time liabilities | 0,2 | 0,4 | 0,3 | -19,7 |
Equity capital | 0,5 | 1,6 | 2,9 | 79,3 |
Operating profit (EBIT) | 1 | 1,2 | 1,4 | 18,9 |
Assets | 0,9 | 2,1 | 3,4 | 56 |
Net profit (loss) | 0,9 | 1,1 | 1,3 | 20,5 |
Cash | 0,1 | 0,4 | 0,8 | 110,6 |
Liabilities and provisions for liabilities | 0,3 | 0,5 | 0,5 | -13,2 |
Net income from sale | 2,4 | 4 | 4,8 | 20,6 |
Working assets | 0,8 | 1,7 | 2,9 | 68,3 |
Depreciation | 0 | 0,1 | 0,1 | 84,3 |
% | % | % | p.p. | |
Profitability of capital | 162,5 | 65,8 | 44,2 | -21,6 |
Equity capital to total assets | 63,3 | 74,8 | 86 | 11,2 |
Gross profit margin | 39,9 | 29,4 | 27,8 | -1,6 |
EBITDA Margin | 42,7 | 31,5 | 31,7 | 0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 32 | 39 | 26 | -13 |
Current financial liquidity indicator | 3.4631810188293457 | 3.798792600631714 | 7.639641761779785 | 3,8 |
Net dept to EBITDA | -0.09877390414476395 | -0.3171928822994232 | -0.5493967533111572 | -0,2 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
ROBIN - EXPERT Marcin Dyduch
Żywiec
GŁÓWNY INSTYTUT GÓRNICTWA
Katowice
INB
Police
Przemysłowy Instytut Motoryzacji
Warszawa